Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/28/2012 | US20120164724 Novel aminotransferase, gene encoding the same, and methods of using them |
06/28/2012 | US20120164709 Recombinant beta-glucosidase variants for production of soluble sugars from cellulosic biomass |
06/28/2012 | US20120164698 Method for fermentatively preparing l-amino acids |
06/28/2012 | US20120164695 Combinatorial variants of glucoamylase with improved specific activity and/or thermostability |
06/28/2012 | US20120164693 Methods of enzymatic discrimination enhancement and surface-bound double-stranded dna |
06/28/2012 | US20120164689 Method for isolating specific genomic regions |
06/28/2012 | US20120164688 High affinity human antibodies to human nerve growth factor |
06/28/2012 | US20120164686 Yeast promoters |
06/28/2012 | US20120164664 T1r taste receptors and genes encoding same |
06/28/2012 | US20120164660 Method for using a diagnostic agent which includes a calcium binding protein assay reagent and assay method for calcium binding protein |
06/28/2012 | US20120164650 Method and means to modulate programmed cell death in eukaryotic cells |
06/28/2012 | US20120164637 Susceptibility to bone damage |
06/28/2012 | US20120164275 Lactic bacterium with modified galactokinase expression for texturizing food products by overexpression of exopolysaccharide |
06/28/2012 | US20120164212 Stem cell beacon |
06/28/2012 | US20120164205 Compositions and methods for control of insect infestations in plants |
06/28/2012 | US20120164171 Antiviral Activity of Bovine Type III Interferon Against Foot-and-Mouth Disease Virus |
06/28/2012 | US20120164169 Bovine herpesvirus vaccine |
06/28/2012 | US20120164167 Sub-region of a plasmodium protein with improved vaccine potential, and medical uses thereof |
06/28/2012 | US20120164166 Neisseria meningitidis antigens and compositions |
06/28/2012 | US20120164165 Zona pellucida binding peptides, expression vectors, compositions, and methods for species-specific immunocontraception of animals |
06/28/2012 | US20120164163 Cdc45l peptides and vaccines including the same |
06/28/2012 | US20120164161 Antibodies and Uses Thereof |
06/28/2012 | US20120164159 Humanised Antibodies to Toll-Like Receptor 2 and Uses Thereof |
06/28/2012 | US20120164153 Monoclonal antibodies against glycoprotein of ebola sudan boniface virus |
06/28/2012 | US20120164147 Mammalian genes; related reagents and methods |
06/28/2012 | US20120164142 Compositions comprising natriuretic peptides and methods of use thereof |
06/28/2012 | US20120164141 Methods and compositions for inducing apoptosis |
06/28/2012 | US20120164140 Hemojuvelin fusion proteins and uses thereof |
06/28/2012 | US20120164130 Modified Factor IX Polypeptides and Uses Thereof |
06/28/2012 | US20120164126 Proteins for use in human and animal staphyococcus infections |
06/28/2012 | US20120164125 Nucleic acid cleaving agent |
06/28/2012 | US20120164118 Cocal vesiculovirus envelope pseudotyped retroviral vectors |
06/28/2012 | US20120164108 Virus strains |
06/28/2012 | US20120164106 Adeno-associated virus virions with variant capsid and methods of use thereof |
06/28/2012 | US20120164105 Construction of a quadruple enterotoxin-deficient mutant of bacillus thuringiensis |
06/28/2012 | US20120164068 Immuno-conjugates and methods for producing them |
06/28/2012 | US20120164066 Antigen-binding proteins comprising recombinant protein scaffolds |
06/28/2012 | DE102009058169B4 Protein oder Polypeptid zur Bindung an Tubulin und/oder Mikrotubulistrukturen Protein or polypeptide to bind to tubulin and / or Mikrotubulistrukturen |
06/28/2012 | CA2825370A1 Continuous directed evolution |
06/28/2012 | CA2824615A1 Endoglucanase variants |
06/28/2012 | CA2824279A1 Modified antibody with improved half-life |
06/28/2012 | CA2824278A1 Modulating agonistic tnfr antibodies |
06/28/2012 | CA2822732A1 Antimicrobial agents |
06/28/2012 | CA2822720A1 Brassica plant comprising a mutant alcatraz allele |
06/28/2012 | CA2822594A1 Bioassay method for detecting physiologically active substance |
06/28/2012 | CA2822559A1 Therapeutic strategies to treat cns pathology in mucopolysaccharidoses |
06/28/2012 | CA2822462A1 Polycomb-associated non-coding rnas |
06/28/2012 | CA2822443A1 Modified influenza hemagglutinin proteins and uses thereof |
06/28/2012 | CA2822377A1 Non-coding immunomodulatory dna construct |
06/28/2012 | CA2822367A1 Dna expression construct |
06/28/2012 | CA2822338A1 Disruption of ahp6 gene leads to plants with improved seed yield |
06/28/2012 | CA2822301A1 Method and agents for producing n-acetykneuraninic acid (neunac) |
06/28/2012 | CA2822289A1 Plant gene expression modulatory sequences from maize |
06/28/2012 | CA2822288A1 Anti-c5/c5a/c5adesr antibodies and fragments |
06/28/2012 | CA2822268A1 Targeted perhydrolases |
06/28/2012 | CA2822004A1 Nematode-resistant transgenic plants |
06/28/2012 | CA2821660A1 Alpha-mannosidases from plants and methods for using the same |
06/28/2012 | CA2821643A1 Method for producing mullerian inhibitor substance in plants |
06/28/2012 | CA2821641A1 Method for producing apolipoprotein in plants |
06/28/2012 | CA2821636A1 Method for expressing deoxyribonuclease in plants |
06/28/2012 | CA2821625A1 Method and system for the vacuum infiltration of plants |
06/28/2012 | CA2821574A1 Virus like particle production in plants |
06/28/2012 | CA2821509A1 Viral promoter, truncations thereof, and methods of use |
06/28/2012 | CA2821397A1 Membrane bound reporter molecules and their use in cell sorting |
06/28/2012 | CA2821378A1 Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms |
06/28/2012 | CA2821257A1 Isolated polynucleotides and polypeptides, and methods of using same for increasing abiotic stress tolerance, yield, growth rate, vigor, biomass, oil content, and/or nitrogen use efficiency of plants |
06/28/2012 | CA2821154A1 Viral promoter, truncations thereof, and methods of use |
06/28/2012 | CA2817984A1 Drought tolerant plants and related constructs and methods involving genes encoding mate-efflux polypeptides |
06/27/2012 | EP2469278A1 Reagentless fluorescent biosensors from nanofitins, rational design methods to create reagentless fluorescent biosensors and methods of their use |
06/27/2012 | EP2468902A1 Corn event MIR162 |
06/27/2012 | EP2468891A2 MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers |
06/27/2012 | EP2468890A2 MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers |
06/27/2012 | EP2468881A2 Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis |
06/27/2012 | EP2468873A1 Plants having enhanced yield-related traits and a method for making the same |
06/27/2012 | EP2468872A1 Method for producing mullerian inhibitor substance in plants |
06/27/2012 | EP2468871A1 Method for producing apolipoprotein in plants |
06/27/2012 | EP2468870A1 Method for expressing desxoyribonuclease in plants |
06/27/2012 | EP2468869A1 Bacterial leader sequences for increased expression |
06/27/2012 | EP2468868A1 Chemotherapeutic sensitizers |
06/27/2012 | EP2468867A1 Methods for identifying biologically active oligonucleotides capable of modulating the immune system |
06/27/2012 | EP2468866A1 Biologically active oligonucleotides capable of modulating the immune system |
06/27/2012 | EP2468865A1 Antisense oligonucleotide modulation of stat3 expression |
06/27/2012 | EP2468864A1 Nucleic acid compounds for inhibiting VEGF family gene expression and uses thereof |
06/27/2012 | EP2468863A1 Therapeutic peptides |
06/27/2012 | EP2468862A1 Method and kit for processing wax-embedded biological samples |
06/27/2012 | EP2468861A1 Method of constructing gene transport support |
06/27/2012 | EP2468860A1 Transformant and process for production thereof, and process for production of lactic acid |
06/27/2012 | EP2468859A1 Novel protein having b-glucosidase activity, and use thereof |
06/27/2012 | EP2468858A1 Fusion protein regulating plasma glucose and lipid, its preparation method and use |
06/27/2012 | EP2468856A1 Antimicrobial Agents |
06/27/2012 | EP2468854A1 High fidelity restriction endonucleases |
06/27/2012 | EP2468848A2 Modified cyanobacteria |
06/27/2012 | EP2468768A2 Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis |
06/27/2012 | EP2468291A1 Activin-ActRII Antagonists and Uses for Increasing Red Blood Cell Levels |
06/27/2012 | EP2468290A1 Activin-ActRII Antagonists and Uses for Increasing Red Blood Cell Levels |
06/27/2012 | EP2467500A1 Detection of aad-1 event das-40278-9 |
06/27/2012 | EP2467499A1 Cstf2 for target genes of lung cancer therapy and diagnosis |
06/27/2012 | EP2467491A1 Methods of using cd44 fusion proteins to treat cancer |
06/27/2012 | EP2467490A1 Production of propanols, alcohols, and polyols in consolidated bioprocessing organisms |
06/27/2012 | EP2467489A2 Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions |